Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity

by Tweats, David J., Johnson, George E., Scandale, Ivan, Whitwell, James, Evans, Dean B.
Published 2016

Letrozole sensitizes breast cancer cells to ionizing radiation

by Azria, David, Larbouret, Christel, Cunat, Severine, Ozsahin, Mahmut, Gourgou, Sophie, Martineau, Pierre, Evans, Dean B, Romieu, Gilles, Pujol, Pascal, Pèlegrin, Andre
Published 2005

Molecular response to aromatase inhibitor treatment in primary breast cancer

by Mackay, Alan, Urruticoechea, Ander, Dixon, J Michael, Dexter, Tim, Fenwick, Kerry, Ashworth, Alan, Drury, Suzanne, Larionov, Alexey, Young, Oliver, White, Sharon, Miller, William R, Evans, Dean B, Dowsett, Mitch
Published 2007

Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo

by Martin, Lesley-Ann, Pancholi, Sunil, Farmer, Ian, Guest, Stephanie, Ribas, Ricardo, Weigel, Marion T, Thornhill, Allan M, Ghazoui, Zara, A'Hern, Roger, Evans, Dean B, Lane, Heidi A, Johnston, Stephen R, Dowsett, Mitch
Published 2012